Global IBS Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one?s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
SCOPE OF THE REPORT:
This report focuses on the IBS Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.
The worldwide market for IBS Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe IBS Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of IBS Treatment, with sales, revenue, and price of IBS Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of IBS Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, IBS Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe IBS Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
SCOPE OF THE REPORT:
This report focuses on the IBS Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.
The worldwide market for IBS Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Allergan Plc (Ireland)
- Sucampo Pharmaceuticals (U.S.)
- Ironwood Pharmaceuticals, Inc. (U.S.)
- Astellas Pharma Inc. (Japan)
- Valeant Pharmaceuticals (Canada)
- Abbott Laboratories (U.S.)
- Synergy Pharmaceuticals, Inc. (U.S.)
- Ardelyx, Inc. (U.S.)
- Nestle (Switzerland)
- Sebela Pharmaceuticals (Ireland)
- Probi (Sweden)
- Alfasigma USA, Inc. (Italy)
- RedHill Biopharma Ltd. (Israel)
- AstraZeneca (U.K)
- Ipsen (France)
- Novartis AG (Switzerland)
- Takeda Pharmaceutical Company Ltd (Japan)
- Synthetic Biologics, Inc. (U.S.)
- Protagonist Therapeutics Inc. (U.S.)
- Pfizer Inc (U.S.)
- Lexicon Pharmaceuticals, Inc. (U.S.)
- Innovate Biopharmaceuticals (U.S.)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- IBS-D
- IBS-C
- IBS-M
- Hospitals
- Clinics
- Research Laboratories
Chapter 1, to describe IBS Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of IBS Treatment, with sales, revenue, and price of IBS Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of IBS Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, IBS Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe IBS Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 IBS Treatment Introduction
1.2 Market Analysis by Type
1.2.1 IBS-D
1.2.2 IBS-C
1.2.3 IBS-M
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Laboratories
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Allergan Plc (Ireland)
2.1.1 Business Overview
2.1.2 IBS Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Plc (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sucampo Pharmaceuticals (U.S.)
2.2.1 Business Overview
2.2.2 IBS Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Ironwood Pharmaceuticals, Inc. (U.S.)
2.3.1 Business Overview
2.3.2 IBS Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astellas Pharma Inc. (Japan)
2.4.1 Business Overview
2.4.2 IBS Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astellas Pharma Inc. (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant Pharmaceuticals (Canada)
2.5.1 Business Overview
2.5.2 IBS Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valeant Pharmaceuticals (Canada) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Laboratories (U.S.)
2.6.1 Business Overview
2.6.2 IBS Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Synergy Pharmaceuticals, Inc. (U.S.)
2.7.1 Business Overview
2.7.2 IBS Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ardelyx, Inc. (U.S.)
2.8.1 Business Overview
2.8.2 IBS Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ardelyx, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nestle (Switzerland)
2.9.1 Business Overview
2.9.2 IBS Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nestle (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sebela Pharmaceuticals (Ireland)
2.10.1 Business Overview
2.10.2 IBS Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Probi (Sweden)
2.11.1 Business Overview
2.11.2 IBS Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Probi (Sweden) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alfasigma USA, Inc. (Italy)
2.12.1 Business Overview
2.12.2 IBS Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Alfasigma USA, Inc. (Italy) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 RedHill Biopharma Ltd. (Israel)
2.13.1 Business Overview
2.13.2 IBS Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 RedHill Biopharma Ltd. (Israel) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 AstraZeneca (U.K)
2.14.1 Business Overview
2.14.2 IBS Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 AstraZeneca (U.K) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ipsen (France)
2.15.1 Business Overview
2.15.2 IBS Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ipsen (France) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Novartis AG (Switzerland)
2.16.1 Business Overview
2.16.2 IBS Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Novartis AG (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Takeda Pharmaceutical Company Ltd (Japan)
2.17.1 Business Overview
2.17.2 IBS Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Synthetic Biologics, Inc. (U.S.)
2.18.1 Business Overview
2.18.2 IBS Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Synthetic Biologics, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Protagonist Therapeutics Inc. (U.S.)
2.19.1 Business Overview
2.19.2 IBS Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Protagonist Therapeutics Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Pfizer Inc (U.S.)
2.20.1 Business Overview
2.20.2 IBS Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Pfizer Inc (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Lexicon Pharmaceuticals, Inc. (U.S.)
2.21.1 Business Overview
2.2.2 IBS Treatment Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Innovate Biopharmaceuticals (U.S.)
2.22.1 Business Overview
2.22.2 IBS Treatment Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL IBS TREATMENT SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global IBS Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global IBS Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 IBS Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 IBS Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL IBS TREATMENT MARKET ANALYSIS BY REGIONS
4.1 Global IBS Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global IBS Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global IBS Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America IBS Treatment Sales and Growth Rate (2013-2018)
4.3 Europe IBS Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific IBS Treatment Sales and Growth Rate (2013-2018)
4.5 South America IBS Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa IBS Treatment Sales and Growth Rate (2013-2018)
5 NORTH AMERICA IBS TREATMENT BY COUNTRIES
5.1 North America IBS Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America IBS Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America IBS Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States IBS Treatment Sales and Growth Rate (2013-2018)
5.3 Canada IBS Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico IBS Treatment Sales and Growth Rate (2013-2018)
6 EUROPE IBS TREATMENT BY COUNTRIES
6.1 Europe IBS Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe IBS Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe IBS Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany IBS Treatment Sales and Growth Rate (2013-2018)
6.3 UK IBS Treatment Sales and Growth Rate (2013-2018)
6.4 France IBS Treatment Sales and Growth Rate (2013-2018)
6.5 Russia IBS Treatment Sales and Growth Rate (2013-2018)
6.6 Italy IBS Treatment Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC IBS TREATMENT BY COUNTRIES
7.1 Asia-Pacific IBS Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific IBS Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific IBS Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China IBS Treatment Sales and Growth Rate (2013-2018)
7.3 Japan IBS Treatment Sales and Growth Rate (2013-2018)
7.4 Korea IBS Treatment Sales and Growth Rate (2013-2018)
7.5 India IBS Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia IBS Treatment Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA IBS TREATMENT BY COUNTRIES
8.1 South America IBS Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America IBS Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America IBS Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil IBS Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina IBS Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia IBS Treatment Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA IBS TREATMENT BY COUNTRIES
9.1 Middle East and Africa IBS Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa IBS Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa IBS Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia IBS Treatment Sales and Growth Rate (2013-2018)
9.3 UAE IBS Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt IBS Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria IBS Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa IBS Treatment Sales and Growth Rate (2013-2018)
10 GLOBAL IBS TREATMENT MARKET SEGMENT BY TYPE
10.1 Global IBS Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global IBS Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global IBS Treatment Revenue and Market Share by Type (2013-2018)
10.2 IBS-D Sales Growth and Price
10.2.1 Global IBS-D Sales Growth (2013-2018)
10.2.2 Global IBS-D Price (2013-2018)
10.3 IBS-C Sales Growth and Price
10.3.1 Global IBS-C Sales Growth (2013-2018)
10.3.2 Global IBS-C Price (2013-2018)
10.4 IBS-M Sales Growth and Price
10.4.1 Global IBS-M Sales Growth (2013-2018)
10.4.2 Global IBS-M Price (2013-2018)
11 GLOBAL IBS TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global IBS Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Research Laboratories Sales Growth (2013-2018)
12 IBS TREATMENT MARKET FORECAST (2018-2023)
12.1 Global IBS Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 IBS Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America IBS Treatment Market Forecast (2018-2023)
12.2.2 Europe IBS Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific IBS Treatment Market Forecast (2018-2023)
12.2.4 South America IBS Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa IBS Treatment Market Forecast (2018-2023)
12.3 IBS Treatment Market Forecast by Type (2018-2023)
12.3.1 Global IBS Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global IBS Treatment Market Share Forecast by Type (2018-2023)
12.4 IBS Treatment Market Forecast by Application (2018-2023)
12.4.1 Global IBS Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global IBS Treatment Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 IBS Treatment Introduction
1.2 Market Analysis by Type
1.2.1 IBS-D
1.2.2 IBS-C
1.2.3 IBS-M
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Laboratories
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Allergan Plc (Ireland)
2.1.1 Business Overview
2.1.2 IBS Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Plc (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sucampo Pharmaceuticals (U.S.)
2.2.1 Business Overview
2.2.2 IBS Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Ironwood Pharmaceuticals, Inc. (U.S.)
2.3.1 Business Overview
2.3.2 IBS Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astellas Pharma Inc. (Japan)
2.4.1 Business Overview
2.4.2 IBS Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astellas Pharma Inc. (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant Pharmaceuticals (Canada)
2.5.1 Business Overview
2.5.2 IBS Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valeant Pharmaceuticals (Canada) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Laboratories (U.S.)
2.6.1 Business Overview
2.6.2 IBS Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Synergy Pharmaceuticals, Inc. (U.S.)
2.7.1 Business Overview
2.7.2 IBS Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ardelyx, Inc. (U.S.)
2.8.1 Business Overview
2.8.2 IBS Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ardelyx, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nestle (Switzerland)
2.9.1 Business Overview
2.9.2 IBS Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nestle (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sebela Pharmaceuticals (Ireland)
2.10.1 Business Overview
2.10.2 IBS Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Probi (Sweden)
2.11.1 Business Overview
2.11.2 IBS Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Probi (Sweden) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alfasigma USA, Inc. (Italy)
2.12.1 Business Overview
2.12.2 IBS Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Alfasigma USA, Inc. (Italy) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 RedHill Biopharma Ltd. (Israel)
2.13.1 Business Overview
2.13.2 IBS Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 RedHill Biopharma Ltd. (Israel) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 AstraZeneca (U.K)
2.14.1 Business Overview
2.14.2 IBS Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 AstraZeneca (U.K) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ipsen (France)
2.15.1 Business Overview
2.15.2 IBS Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ipsen (France) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Novartis AG (Switzerland)
2.16.1 Business Overview
2.16.2 IBS Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Novartis AG (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Takeda Pharmaceutical Company Ltd (Japan)
2.17.1 Business Overview
2.17.2 IBS Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Synthetic Biologics, Inc. (U.S.)
2.18.1 Business Overview
2.18.2 IBS Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Synthetic Biologics, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Protagonist Therapeutics Inc. (U.S.)
2.19.1 Business Overview
2.19.2 IBS Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Protagonist Therapeutics Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Pfizer Inc (U.S.)
2.20.1 Business Overview
2.20.2 IBS Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Pfizer Inc (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Lexicon Pharmaceuticals, Inc. (U.S.)
2.21.1 Business Overview
2.2.2 IBS Treatment Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Innovate Biopharmaceuticals (U.S.)
2.22.1 Business Overview
2.22.2 IBS Treatment Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL IBS TREATMENT SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global IBS Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global IBS Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 IBS Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 IBS Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL IBS TREATMENT MARKET ANALYSIS BY REGIONS
4.1 Global IBS Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global IBS Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global IBS Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America IBS Treatment Sales and Growth Rate (2013-2018)
4.3 Europe IBS Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific IBS Treatment Sales and Growth Rate (2013-2018)
4.5 South America IBS Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa IBS Treatment Sales and Growth Rate (2013-2018)
5 NORTH AMERICA IBS TREATMENT BY COUNTRIES
5.1 North America IBS Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America IBS Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America IBS Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States IBS Treatment Sales and Growth Rate (2013-2018)
5.3 Canada IBS Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico IBS Treatment Sales and Growth Rate (2013-2018)
6 EUROPE IBS TREATMENT BY COUNTRIES
6.1 Europe IBS Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe IBS Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe IBS Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany IBS Treatment Sales and Growth Rate (2013-2018)
6.3 UK IBS Treatment Sales and Growth Rate (2013-2018)
6.4 France IBS Treatment Sales and Growth Rate (2013-2018)
6.5 Russia IBS Treatment Sales and Growth Rate (2013-2018)
6.6 Italy IBS Treatment Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC IBS TREATMENT BY COUNTRIES
7.1 Asia-Pacific IBS Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific IBS Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific IBS Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China IBS Treatment Sales and Growth Rate (2013-2018)
7.3 Japan IBS Treatment Sales and Growth Rate (2013-2018)
7.4 Korea IBS Treatment Sales and Growth Rate (2013-2018)
7.5 India IBS Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia IBS Treatment Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA IBS TREATMENT BY COUNTRIES
8.1 South America IBS Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America IBS Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America IBS Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil IBS Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina IBS Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia IBS Treatment Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA IBS TREATMENT BY COUNTRIES
9.1 Middle East and Africa IBS Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa IBS Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa IBS Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia IBS Treatment Sales and Growth Rate (2013-2018)
9.3 UAE IBS Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt IBS Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria IBS Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa IBS Treatment Sales and Growth Rate (2013-2018)
10 GLOBAL IBS TREATMENT MARKET SEGMENT BY TYPE
10.1 Global IBS Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global IBS Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global IBS Treatment Revenue and Market Share by Type (2013-2018)
10.2 IBS-D Sales Growth and Price
10.2.1 Global IBS-D Sales Growth (2013-2018)
10.2.2 Global IBS-D Price (2013-2018)
10.3 IBS-C Sales Growth and Price
10.3.1 Global IBS-C Sales Growth (2013-2018)
10.3.2 Global IBS-C Price (2013-2018)
10.4 IBS-M Sales Growth and Price
10.4.1 Global IBS-M Sales Growth (2013-2018)
10.4.2 Global IBS-M Price (2013-2018)
11 GLOBAL IBS TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global IBS Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Research Laboratories Sales Growth (2013-2018)
12 IBS TREATMENT MARKET FORECAST (2018-2023)
12.1 Global IBS Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 IBS Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America IBS Treatment Market Forecast (2018-2023)
12.2.2 Europe IBS Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific IBS Treatment Market Forecast (2018-2023)
12.2.4 South America IBS Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa IBS Treatment Market Forecast (2018-2023)
12.3 IBS Treatment Market Forecast by Type (2018-2023)
12.3.1 Global IBS Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global IBS Treatment Market Share Forecast by Type (2018-2023)
12.4 IBS Treatment Market Forecast by Application (2018-2023)
12.4.1 Global IBS Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global IBS Treatment Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure IBS Treatment Picture
Table Product Specifications of IBS Treatment
Figure Global Sales Market Share of IBS Treatment by Types in 2017
Table IBS Treatment Types for Major Manufacturers
Figure IBS-D Picture
Figure IBS-C Picture
Figure IBS-M Picture
Figure IBS Treatment Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Laboratories Picture
Figure United States IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Canada IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Germany IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure France IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure UK IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Russia IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Italy IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure China IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Japan IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Korea IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure India IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Table Allergan Plc (Ireland) Basic Information, Manufacturing Base and Competitors
Table Allergan Plc (Ireland) IBS Treatment Type and Applications
Table Allergan Plc (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sucampo Pharmaceuticals (U.S.) Basic Information, Manufacturing Base and Competitors
Table Sucampo Pharmaceuticals (U.S.) IBS Treatment Type and Applications
Table Sucampo Pharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ironwood Pharmaceuticals, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Type and Applications
Table Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Inc. (Japan) Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Inc. (Japan) IBS Treatment Type and Applications
Table Astellas Pharma Inc. (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals (Canada) Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals (Canada) IBS Treatment Type and Applications
Table Valeant Pharmaceuticals (Canada) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories (U.S.) Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories (U.S.) IBS Treatment Type and Applications
Table Abbott Laboratories (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synergy Pharmaceuticals, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Type and Applications
Table Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ardelyx, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Ardelyx, Inc. (U.S.) IBS Treatment Type and Applications
Table Ardelyx, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nestle (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Nestle (Switzerland) IBS Treatment Type and Applications
Table Nestle (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sebela Pharmaceuticals (Ireland) Basic Information, Manufacturing Base and Competitors
Table Sebela Pharmaceuticals (Ireland) IBS Treatment Type and Applications
Table Sebela Pharmaceuticals (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Probi (Sweden) Basic Information, Manufacturing Base and Competitors
Table Probi (Sweden) IBS Treatment Type and Applications
Table Probi (Sweden) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alfasigma USA, Inc. (Italy) Basic Information, Manufacturing Base and Competitors
Table Alfasigma USA, Inc. (Italy) IBS Treatment Type and Applications
Table Alfasigma USA, Inc. (Italy) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table RedHill Biopharma Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table RedHill Biopharma Ltd. (Israel) IBS Treatment Type and Applications
Table RedHill Biopharma Ltd. (Israel) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca (U.K) Basic Information, Manufacturing Base and Competitors
Table AstraZeneca (U.K) IBS Treatment Type and Applications
Table AstraZeneca (U.K) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen (France) Basic Information, Manufacturing Base and Competitors
Table Ipsen (France) IBS Treatment Type and Applications
Table Ipsen (France) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Novartis AG (Switzerland) IBS Treatment Type and Applications
Table Novartis AG (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Company Ltd (Japan) Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Type and Applications
Table Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics, Inc. (U.S.) IBS Treatment Type and Applications
Table Synthetic Biologics, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Protagonist Therapeutics Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Protagonist Therapeutics Inc. (U.S.) IBS Treatment Type and Applications
Table Protagonist Therapeutics Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc (U.S.) Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc (U.S.) IBS Treatment Type and Applications
Table Pfizer Inc (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lexicon Pharmaceuticals, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Type and Applications
Table Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Innovate Biopharmaceuticals (U.S.) Basic Information, Manufacturing Base and Competitors
Table Innovate Biopharmaceuticals (U.S.) IBS Treatment Type and Applications
Table Innovate Biopharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global IBS Treatment Sales by Manufacturer (2016-2017)
Figure Global IBS Treatment Sales Market Share by Manufacturer in 2016
Figure Global IBS Treatment Sales Market Share by Manufacturer in 2017
Table Global IBS Treatment Revenue by Manufacturer (2016-2017)
Figure Global IBS Treatment Revenue Market Share by Manufacturer in 2016
Figure Global IBS Treatment Revenue Market Share by Manufacturer in 2017
Figure Top 3 IBS Treatment Manufacturer (Revenue) Market Share in 2017
Figure Top 6 IBS Treatment Manufacturer (Revenue) Market Share in 2017
Figure Global IBS Treatment Sales and Growth Rate (2013-2018)
Figure Global IBS Treatment Revenue and Growth Rate (2013-2018)
Table Global IBS Treatment Sales by Regions (2013-2018)
Table Global IBS Treatment Sales Market Share by Regions (2013-2018)
Table Global IBS Treatment Revenue by Regions (2013-2018)
Figure Global IBS Treatment Revenue Market Share by Regions in 2013
Figure Global IBS Treatment Revenue Market Share by Regions in 2017
Figure North America IBS Treatment Sales and Growth Rate (2013-2018)
Figure Europe IBS Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific IBS Treatment Sales and Growth Rate (2013-2018)
Figure South America IBS Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa IBS Treatment Sales and Growth Rate (2013-2018)
Figure North America IBS Treatment Revenue and Growth Rate (2013-2018)
Table North America IBS Treatment Sales by Countries (2013-2018)
Table North America IBS Treatment Sales Market Share by Countries (2013-2018)
Figure North America IBS Treatment Sales Market Share by Countries in 2013
Figure North America IBS Treatment Sales Market Share by Countries in 2017
Table North America IBS Treatment Revenue by Countries (2013-2018)
Table North America IBS Treatment Revenue Market Share by Countries (2013-2018)
Figure North America IBS Treatment Revenue Market Share by Countries in 2013
Figure North America IBS Treatment Revenue Market Share by Countries in 2017
Figure United States IBS Treatment Sales and Growth Rate (2013-2018)
Figure Canada IBS Treatment Sales and Growth Rate (2013-2018)
Figure Mexico IBS Treatment Sales and Growth Rate (2013-2018)
Figure Europe IBS Treatment Revenue and Growth Rate (2013-2018)
Table Europe IBS Treatment Sales by Countries (2013-2018)
Table Europe IBS Treatment Sales Market Share by Countries (2013-2018)
Table Europe IBS Treatment Revenue by Countries (2013-2018)
Figure Europe IBS Treatment Revenue Market Share by Countries in 2016
Figure Europe IBS Treatment Revenue Market Share by Countries in 2017
Figure Germany IBS Treatment Sales and Growth Rate (2013-2018)
Figure UK IBS Treatment Sales and Growth Rate (2013-2018)
Figure France IBS Treatment Sales and Growth Rate (2013-2018)
Figure Russia IBS Treatment Sales and Growth Rate (2013-2018)
Figure Italy IBS Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific IBS Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific IBS Treatment Sales by Countries (2013-2018)
Table Asia-Pacific IBS Treatment Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific IBS Treatment Sales Market Share by Countries 2017
Table Asia-Pacific IBS Treatment Revenue by Countries (2013-2018)
Figure Asia-Pacific IBS Treatment Revenue Market Share by Countries 2017
Figure China IBS Treatment Sales and Growth Rate (2013-2018)
Figure Japan IBS Treatment Sales and Growth Rate (2013-2018)
Figure Korea IBS Treatment Sales and Growth Rate (2013-2018)
Figure India IBS Treatment Sales and Growth Rate (2013-2018)
Figure Southeast Asia IBS Treatment Sales and Growth Rate (2013-2018)
Figure South America IBS Treatment Revenue and Growth Rate (2013-2018)
Table South America IBS Treatment Sales by Countries (2013-2018)
Table South America IBS Treatment Sales Market Share by Countries (2013-2018)
Figure South America IBS Treatment Sales Market Share by Countries in 2017
Table South America IBS Treatment Revenue by Countries (2013-2018)
Table South America IBS Treatment Revenue Market Share by Countries (2013-2018)
Figure South America IBS Treatment Revenue Market Share by Countries in 2017
Figure Brazil IBS Treatment Sales and Growth Rate (2013-2018)
Figure Argentina IBS Treatment Sales and Growth Rate (2013-2018)
Figure Colombia IBS Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa IBS Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa IBS Treatment Sales by Countries (2013-2018)
Table Middle East and Africa IBS Treatment Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa IBS Treatment Sales Market Share by Countries in 2017
Table Middle East and Africa IBS Treatment Revenue by Countries (2013-2018)
Table Middle East and Africa IBS Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa IBS Treatment Revenue Market Share by Countries in 2013
Figure Middle East and Africa IBS Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia IBS Treatment Sales and Growth Rate (2013-2018)
Figure UAE IBS Treatment Sales and Growth Rate (2013-2018)
Figure Egypt IBS Treatment Sales and Growth Rate (2013-2018)
Figure Nigeria IBS Treatment Sales and Growth Rate (2013-2018)
Figure South Africa IBS Treatment Sales and Growth Rate (2013-2018)
Table Global IBS Treatment Sales by Type (2013-2018)
Table Global IBS Treatment Sales Share by Type (2013-2018)
Table Global IBS Treatment Revenue by Type (2013-2018)
Table Global IBS Treatment Revenue Share by Type (2013-2018)
Figure Global IBS-D Sales Growth (2013-2018)
Figure Global IBS-D Price (2013-2018)
Figure Global IBS-C Sales Growth (2013-2018)
Figure Global IBS-C Price (2013-2018)
Figure Global IBS-M Sales Growth (2013-2018)
Figure Global IBS-M Price (2013-2018)
Table Global IBS Treatment Sales by Application (2013-2018)
Table Global IBS Treatment Sales Share by Application (2013-2018)
Figure Global Clinics Sales Growth (2013-2018)
Figure Global Research Laboratories Sales Growth (2013-2018)
Figure Global IBS Treatment Sales, Revenue and Growth Rate (2018-2023)
Table Global IBS Treatment Sales Forecast by Regions (2018-2023)
Table Global IBS Treatment Market Share Forecast by Regions (2018-2023)
Figure North America Sales IBS Treatment Market Forecast (2018-2023)
Figure Europe Sales IBS Treatment Market Forecast (2018-2023)
Figure Asia-Pacific Sales IBS Treatment Market Forecast (2018-2023)
Figure South America Sales IBS Treatment Market Forecast (2018-2023)
Figure Middle East and Africa Sales IBS Treatment Market Forecast (2018-2023)
Table Global IBS Treatment Sales Forecast by Type (2018-2023)
Table Global IBS Treatment Market Share Forecast by Type (2018-2023)
Table Global IBS Treatment Sales Forecast by Application (2018-2023)
Table Global IBS Treatment Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure IBS Treatment Picture
Table Product Specifications of IBS Treatment
Figure Global Sales Market Share of IBS Treatment by Types in 2017
Table IBS Treatment Types for Major Manufacturers
Figure IBS-D Picture
Figure IBS-C Picture
Figure IBS-M Picture
Figure IBS Treatment Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Laboratories Picture
Figure United States IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Canada IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Germany IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure France IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure UK IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Russia IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Italy IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure China IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Japan IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Korea IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure India IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria IBS Treatment Revenue (Value) and Growth Rate (2013-2023)
Table Allergan Plc (Ireland) Basic Information, Manufacturing Base and Competitors
Table Allergan Plc (Ireland) IBS Treatment Type and Applications
Table Allergan Plc (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sucampo Pharmaceuticals (U.S.) Basic Information, Manufacturing Base and Competitors
Table Sucampo Pharmaceuticals (U.S.) IBS Treatment Type and Applications
Table Sucampo Pharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ironwood Pharmaceuticals, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Type and Applications
Table Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Inc. (Japan) Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Inc. (Japan) IBS Treatment Type and Applications
Table Astellas Pharma Inc. (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals (Canada) Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals (Canada) IBS Treatment Type and Applications
Table Valeant Pharmaceuticals (Canada) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories (U.S.) Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories (U.S.) IBS Treatment Type and Applications
Table Abbott Laboratories (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synergy Pharmaceuticals, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Type and Applications
Table Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ardelyx, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Ardelyx, Inc. (U.S.) IBS Treatment Type and Applications
Table Ardelyx, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nestle (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Nestle (Switzerland) IBS Treatment Type and Applications
Table Nestle (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sebela Pharmaceuticals (Ireland) Basic Information, Manufacturing Base and Competitors
Table Sebela Pharmaceuticals (Ireland) IBS Treatment Type and Applications
Table Sebela Pharmaceuticals (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Probi (Sweden) Basic Information, Manufacturing Base and Competitors
Table Probi (Sweden) IBS Treatment Type and Applications
Table Probi (Sweden) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alfasigma USA, Inc. (Italy) Basic Information, Manufacturing Base and Competitors
Table Alfasigma USA, Inc. (Italy) IBS Treatment Type and Applications
Table Alfasigma USA, Inc. (Italy) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table RedHill Biopharma Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table RedHill Biopharma Ltd. (Israel) IBS Treatment Type and Applications
Table RedHill Biopharma Ltd. (Israel) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca (U.K) Basic Information, Manufacturing Base and Competitors
Table AstraZeneca (U.K) IBS Treatment Type and Applications
Table AstraZeneca (U.K) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen (France) Basic Information, Manufacturing Base and Competitors
Table Ipsen (France) IBS Treatment Type and Applications
Table Ipsen (France) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Novartis AG (Switzerland) IBS Treatment Type and Applications
Table Novartis AG (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Company Ltd (Japan) Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Type and Applications
Table Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics, Inc. (U.S.) IBS Treatment Type and Applications
Table Synthetic Biologics, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Protagonist Therapeutics Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Protagonist Therapeutics Inc. (U.S.) IBS Treatment Type and Applications
Table Protagonist Therapeutics Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc (U.S.) Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc (U.S.) IBS Treatment Type and Applications
Table Pfizer Inc (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lexicon Pharmaceuticals, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Type and Applications
Table Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Innovate Biopharmaceuticals (U.S.) Basic Information, Manufacturing Base and Competitors
Table Innovate Biopharmaceuticals (U.S.) IBS Treatment Type and Applications
Table Innovate Biopharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global IBS Treatment Sales by Manufacturer (2016-2017)
Figure Global IBS Treatment Sales Market Share by Manufacturer in 2016
Figure Global IBS Treatment Sales Market Share by Manufacturer in 2017
Table Global IBS Treatment Revenue by Manufacturer (2016-2017)
Figure Global IBS Treatment Revenue Market Share by Manufacturer in 2016
Figure Global IBS Treatment Revenue Market Share by Manufacturer in 2017
Figure Top 3 IBS Treatment Manufacturer (Revenue) Market Share in 2017
Figure Top 6 IBS Treatment Manufacturer (Revenue) Market Share in 2017
Figure Global IBS Treatment Sales and Growth Rate (2013-2018)
Figure Global IBS Treatment Revenue and Growth Rate (2013-2018)
Table Global IBS Treatment Sales by Regions (2013-2018)
Table Global IBS Treatment Sales Market Share by Regions (2013-2018)
Table Global IBS Treatment Revenue by Regions (2013-2018)
Figure Global IBS Treatment Revenue Market Share by Regions in 2013
Figure Global IBS Treatment Revenue Market Share by Regions in 2017
Figure North America IBS Treatment Sales and Growth Rate (2013-2018)
Figure Europe IBS Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific IBS Treatment Sales and Growth Rate (2013-2018)
Figure South America IBS Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa IBS Treatment Sales and Growth Rate (2013-2018)
Figure North America IBS Treatment Revenue and Growth Rate (2013-2018)
Table North America IBS Treatment Sales by Countries (2013-2018)
Table North America IBS Treatment Sales Market Share by Countries (2013-2018)
Figure North America IBS Treatment Sales Market Share by Countries in 2013
Figure North America IBS Treatment Sales Market Share by Countries in 2017
Table North America IBS Treatment Revenue by Countries (2013-2018)
Table North America IBS Treatment Revenue Market Share by Countries (2013-2018)
Figure North America IBS Treatment Revenue Market Share by Countries in 2013
Figure North America IBS Treatment Revenue Market Share by Countries in 2017
Figure United States IBS Treatment Sales and Growth Rate (2013-2018)
Figure Canada IBS Treatment Sales and Growth Rate (2013-2018)
Figure Mexico IBS Treatment Sales and Growth Rate (2013-2018)
Figure Europe IBS Treatment Revenue and Growth Rate (2013-2018)
Table Europe IBS Treatment Sales by Countries (2013-2018)
Table Europe IBS Treatment Sales Market Share by Countries (2013-2018)
Table Europe IBS Treatment Revenue by Countries (2013-2018)
Figure Europe IBS Treatment Revenue Market Share by Countries in 2016
Figure Europe IBS Treatment Revenue Market Share by Countries in 2017
Figure Germany IBS Treatment Sales and Growth Rate (2013-2018)
Figure UK IBS Treatment Sales and Growth Rate (2013-2018)
Figure France IBS Treatment Sales and Growth Rate (2013-2018)
Figure Russia IBS Treatment Sales and Growth Rate (2013-2018)
Figure Italy IBS Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific IBS Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific IBS Treatment Sales by Countries (2013-2018)
Table Asia-Pacific IBS Treatment Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific IBS Treatment Sales Market Share by Countries 2017
Table Asia-Pacific IBS Treatment Revenue by Countries (2013-2018)
Figure Asia-Pacific IBS Treatment Revenue Market Share by Countries 2017
Figure China IBS Treatment Sales and Growth Rate (2013-2018)
Figure Japan IBS Treatment Sales and Growth Rate (2013-2018)
Figure Korea IBS Treatment Sales and Growth Rate (2013-2018)
Figure India IBS Treatment Sales and Growth Rate (2013-2018)
Figure Southeast Asia IBS Treatment Sales and Growth Rate (2013-2018)
Figure South America IBS Treatment Revenue and Growth Rate (2013-2018)
Table South America IBS Treatment Sales by Countries (2013-2018)
Table South America IBS Treatment Sales Market Share by Countries (2013-2018)
Figure South America IBS Treatment Sales Market Share by Countries in 2017
Table South America IBS Treatment Revenue by Countries (2013-2018)
Table South America IBS Treatment Revenue Market Share by Countries (2013-2018)
Figure South America IBS Treatment Revenue Market Share by Countries in 2017
Figure Brazil IBS Treatment Sales and Growth Rate (2013-2018)
Figure Argentina IBS Treatment Sales and Growth Rate (2013-2018)
Figure Colombia IBS Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa IBS Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa IBS Treatment Sales by Countries (2013-2018)
Table Middle East and Africa IBS Treatment Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa IBS Treatment Sales Market Share by Countries in 2017
Table Middle East and Africa IBS Treatment Revenue by Countries (2013-2018)
Table Middle East and Africa IBS Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa IBS Treatment Revenue Market Share by Countries in 2013
Figure Middle East and Africa IBS Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia IBS Treatment Sales and Growth Rate (2013-2018)
Figure UAE IBS Treatment Sales and Growth Rate (2013-2018)
Figure Egypt IBS Treatment Sales and Growth Rate (2013-2018)
Figure Nigeria IBS Treatment Sales and Growth Rate (2013-2018)
Figure South Africa IBS Treatment Sales and Growth Rate (2013-2018)
Table Global IBS Treatment Sales by Type (2013-2018)
Table Global IBS Treatment Sales Share by Type (2013-2018)
Table Global IBS Treatment Revenue by Type (2013-2018)
Table Global IBS Treatment Revenue Share by Type (2013-2018)
Figure Global IBS-D Sales Growth (2013-2018)
Figure Global IBS-D Price (2013-2018)
Figure Global IBS-C Sales Growth (2013-2018)
Figure Global IBS-C Price (2013-2018)
Figure Global IBS-M Sales Growth (2013-2018)
Figure Global IBS-M Price (2013-2018)
Table Global IBS Treatment Sales by Application (2013-2018)
Table Global IBS Treatment Sales Share by Application (2013-2018)
Figure Global Clinics Sales Growth (2013-2018)
Figure Global Research Laboratories Sales Growth (2013-2018)
Figure Global IBS Treatment Sales, Revenue and Growth Rate (2018-2023)
Table Global IBS Treatment Sales Forecast by Regions (2018-2023)
Table Global IBS Treatment Market Share Forecast by Regions (2018-2023)
Figure North America Sales IBS Treatment Market Forecast (2018-2023)
Figure Europe Sales IBS Treatment Market Forecast (2018-2023)
Figure Asia-Pacific Sales IBS Treatment Market Forecast (2018-2023)
Figure South America Sales IBS Treatment Market Forecast (2018-2023)
Figure Middle East and Africa Sales IBS Treatment Market Forecast (2018-2023)
Table Global IBS Treatment Sales Forecast by Type (2018-2023)
Table Global IBS Treatment Market Share Forecast by Type (2018-2023)
Table Global IBS Treatment Sales Forecast by Application (2018-2023)
Table Global IBS Treatment Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
